Arena Pharmaceuticals Inc (ARNA)

NASDAQ
99.99
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    99.97 - 100.00
  • 52 wk Range:
    45.50 - 100.00
Trading near 52-week High

ARNA Overview

Prev. Close
99.99
Day's Range
99.97-100
Revenue
54K
Open
99.97
52 wk Range
45.5-100
EPS
-10.14
Volume
0
Market Cap
6.17B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,478,751
P/E Ratio
-9.86
Beta
0.541
1-Year Change
94.23%
Shares Outstanding
61,659,385
Next Earnings Date
-
What is your sentiment on Arena Pharma?
or
Market is currently closed. Voting is open during market hours.

Arena Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Arena Pharmaceuticals Inc Analysis

Arena Pharmaceuticals Inc Company Profile

Arena Pharmaceuticals Inc Company Profile

Employees
448

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company’s investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn’s disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsBuyBuyBuyStrong BuyStrong Buy
SummaryNeutralStrong BuyBuyStrong BuyStrong Buy
  • Next on the list MYOV. Great value
    0